MiNK Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
MiNK Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2020 to Q1 2022.
  • MiNK Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2022 was $848K, a 14% increase year-over-year.
  • MiNK Therapeutics, Inc. annual Interest Expense for 2021 was $2.43M, a 0.38% decline from 2020.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $848K +$104K +14% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q3 2021 $881K +$242K +37.9% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-29
Q1 2021 $744K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $639K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.